Spots Global Cancer Trial Database for Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

Official Title:

Study ID: NCT02849015

Conditions

Liver Tumor

Evidence of Liver Transplantation

Interventions

Cryosurgery

NK immunotherapy

Study Description

Brief Summary: The aim of this study is the safety and efficacy of cryosurgery plus natural killer(NK) immunotherapy to tumors in transplanted liver.

Detailed Description: By enrolling patients with tumors in transplanted liver adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and NK cells. The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).